This year, the Longevity Forum once again hosted “Longevity Week“, a premier international event focusing on the burgeoning field of longevity medicine. Held in London, the event attracted eminent personalities including Professor Andrew J Scott, a renowned economist and co-author of ‘The New Long Life’ and ‘The 100-Year Life’. Joining him were Dr Peter Attia, a distinguished expert in longevity medicine, alongside billionaires Jim Mellon, co-founder of the Longevity Forum, and Bryan Johnson, an American entrepreneur famous for his anti-ageing endeavours. 

During the Week, the AEON Foundation, an organisation leader in longevity medicine research and policy, hosted a broad discussion on longevity policies, an emerging domain aimed at crafting public health strategies for healthy ageing and prevention. This discussion drew upon advanced biotechnology and artificial intelligence tools. 

The event was graced by illustrious guests such as Andrew Steele, scientist and author; Andrea Maier, president of the Healthy Longevity Medicine Society; Antonella Santuccione, CEO of the Women Brain Project; Elena Bonetti, member of Parliament and former minister; and Silvio Garattini, founder of the Mario Negri Institute. 

Participants unanimously emphasised the necessity and inevitability of transforming public health into a preventive healthcare model. Elena Bonetti underscored the need for bold policies to foster this shift in the medical sector. Additionally, Professor Silvio Garattini highlighted the current focus of medicine on care and treatment, noting that a preventive approach could significantly reduce the prevalence of societal afflictions like cancer and diabetes. Similarly, Antonella Santuccione, remembering the important research contribution of the Women’s Brain Project, underlined that women suffer more comorbidities than men and that we need to focus on specific and tailored preventive campaigns for women, thus achieving precise prevention and precise longevity. 

In this regard, the Women’s Brain Project (WBP), a global organisation dedicated to addressing gender-specific aspects of brain health, is currently fostering a series of important research projects and educational programs, aimed at creating prevention strategies and healthy longevity for women. 

The AEON Foundation, along with other international associations including the Longevity Forum and the Women’s Brain project, is committed to raising awareness about the value of the longevity medicine approach among businesses and institutions. Dr. Nicola Marino, director of the AEON Foundation, remarked, “The essence of developing longevity policies lies not in merely extending life but in enhancing its quality, and fostering a balanced system that accommodates a demographically complex population.” He added, “An interdisciplinary approach is vital for healthy longevity, integrating ageing biology research with biotechnological and information technology advancements like AI algorithms and remote monitoring devices. This approach aims to narrow the gap between life expectancy and health, promoting genuinely preventive and participatory medicine.” 

In the ambit of ambitious health objectives, transforming scientific breakthroughs into policies that extend healthy human life is critical. This holistic approach necessitates interventions at individual, societal, and population levels, countering ageing-related issues like multi-morbidity and frailty. Strengthened by the latest in technology and ageing biology research, including the use of various biomarkers, these strategies are crucial for better ageing management. As Peter Attia pointed out, focusing on not just lifespan but also the quality of physical, cognitive, and emotional health can lead to significant improvements in both longevity and life quality. 

Recent studies in longevity are shedding light on the economic and social impacts of an ageing population. A study in Nature Aging by Andrew J Scott and the acclaimed scientist David Sinclair suggests that each additional year of healthy life expectancy could generate an estimated economic benefit of $38 trillion annually in the United States. Increased longevity implies not just a longer life but an enhanced one, with healthier, more active individuals contributing both through consumption and active workforce participation. This dual benefit offers direct economic advantages for businesses and the economy while reducing healthcare and assistance costs. 

Professor Scott, speaking at the event, noted, “The ageing society presents benefits that will impact us both individually and collectively.” He stressed the importance of investments in scientific research, institutional commitment to longevity policies, and innovation in preventive care to realise these benefits. 

About the Women’s Brain Project:
WBP is an international organisation studying sex and gender determinants of brain and mental health with the
goal of achieving precision medicine and better care for all. WBP is a global leading player in the field of brain
research, supporting and promoting innovative science, unbiased AI and gender health equity to make healthcare
systems more sustainable. The Women’s Brain Foundation, expected to be operational in Q1 2024, will oversee the
first-of-its-kind, Research Institute for Sex and Gender Precision Medicine.

For more information, please visit:

Leave a Reply

Your email address will not be published. Required fields are marked *